Insider sale
KYMERA THERAPEUTICS, INC.
$18.27M
200K shares
What this filing means
ATLAS VENTURE FUND X, L.P. plans to sell 200K shares of KYMERA THERAPEUTICS, INC. valued at approximately $18.27M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001628280-26-013330
10% Owner
Since Aug 2020
200K
Shares to sell
$18.27M
Approx. market value
200K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
3/11/2020
200KTotal acquired200K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/11/2020 | Private Placement Cash | 200K | — |
| Total | 200K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
200K
Market value
$18.27M
3/2/2026
Total
Units
200K
Value
$18.27M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/2/2026 | 200K | $18.27M | Nasdaq | Planned |
| Total | 200K | $18.27M | ||